Filing Details

Accession Number:
0001140361-16-066762
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 21:50:02
Reporting Period:
2016-05-19
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 21:50:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1294935 M Jerome Hauer 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-19 5,985 $0.00 20,085 No 4 A Direct
Common Stock Disposition 2016-05-19 3,134 $41.22 16,951 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
  2. The restricted stock units vest in three equal annual tranches beginning in May 2017.
  3. The restricted stock units vest annually in May 2016 through May 2018.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.20 to $41.30, inclusive.